Antibody therapy against coronavirus (COVID-19)

Project Information

ATAC

Grant agreement ID: 101003650

DOI

10.3030/101003650

Project closed

EC signature date 6 April 2020

Start date 1 April 2020

End date 31 July 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 5 620 040,00

EU contribution

€ 5 595 040,00

Coordinated by

KAROLINSKA INSTITUTET
Sweden